NCT02546570View on ClinicalTrials.gov

Oxytocin and Affect Processing in Posttraumatic Stress Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Posttraumatic Stress Disorder (PTSD)
Interventions
DRUG

Oxytocin

See arm/group descriptions for dosage amount and procedure.

DRUG

Placebo

See arm/group descriptions for dosage amount and procedure.

Trial Locations (1)

06520

Yale University, New Haven

All Listed Sponsors
collaborator

National Center for PTSD

FED

lead

Yale University

OTHER

NCT02546570 - Oxytocin and Affect Processing in Posttraumatic Stress Disorder | Biotech Hunter | Biotech Hunter